Prevention of early postoperative seizures in patients with primary brain tumors: Preliminary experience with oxcarbazepine

Journal of Neuro-Oncology

Volumn 81, Issue 3, 2007, Pages 279-285

  Mauro, Anna Maria ^a   Bomprezzi, Chiara ^a   Morresi, Simonetta ^a   Provinciali, Leandro ^a   Formica, Francesco ^a   Iacoangeli, Maurizio ^a   Scerrati, Massimo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Antiepileptic drugs; Brain tumors; Early seizures; Oxcarbazepine; Surgery

Indexed keywords

LORAZEPAM; OXCARBAZEPINE;

ADULT; AGED; ARTICLE; ATAXIA; CONTROLLED STUDY; DROWSINESS; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; EXPERIENCE; FEMALE; GLIOMA; HEMATOLOGIC DISEASE; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RASH; TREATMENT OUTCOME;

ANTICONVULSANTS; CARBAMAZEPINE; GLIOMA; HUMANS; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEIZURES; SUPRATENTORIAL NEOPLASMS;

EID: 33846476820     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9229-7     Document Type: Article

References (40)

1. Foy PM, Copeland GP, Shaw MDM (1981) The natural history of postoperative seizures. Acta Neurochir 57:15-22
2. Foy PM, Chadwick DW, Rajgopalan N, Johnson AL, Shaw MD (1992) Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 55:753-757
3. DeSantis A, Villani R, Sinisi M, Stocchetti N, Perucca E (2002) Add-on Phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: A randomized controlled study. Epilepsia 43(2):175-182
4. Beenem LFM, Lindeboom J, Kasteleijn-Nolst Trenitè DGA, Heimans JJ, Snoek FJ, Touw DJ, Adèr HJ, van Alphen HAM (1999) Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: Efficacy, tolerability, and cognitive effects. J Neurol Neurosurg Psychiatry 67:474-480
5. Matthew E, Sherwin AL, Welner SA, Odusote K, Stratford JG (1980) Seizures following intracranial surgery: Incidence in the first post-operative week. Can J Neurol Sci 7:285-290
6. Kuijlen JM, Teernstra OP, Kessels AG, Herpers MJ, Beuls EA (1996) Effectiveness of antiepileptic drug prophylaxis used in supratentorial craniotomies. A meta-analysis. Seizure 5:291-298
7. DeSantis A (1991) Diffusion of antiepileptic prophylaxis in Italy. In: Murri L, Parenti G, Annegers JF (eds) Pharmacological prophylaxis of posttraumatic epilepsy. Piccin Edizioni, Padua, pp 95-112
8. Perucca E (1996) Priciples of drug treatment. In: Shorvon SD, Dreifuss F, Fish D (eds) The treatment of epilepsy. Blackwell Science, Oxford, pp 162-168
9. Glantz M, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54:1886-1893
10. Lee ST, Lui TN, Chang CN, Cheng WC, Wang DJ, Heimburger RF, Lin CG (1989) Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 31:361-364
11. Kvuam DA, Loftus CM, Copeland B, Quest DO (1983) Seizures during the immediate postoperative period. Neurosurgery 12(1):14-17
12. North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and post-operative epilepsy: A double-blind study. J Neurosurg 58:672-677
13. Temkin NR (2002) Prophylactic anticonvulsants after neurosurgery. Epilepsy Curr 2(4):105-107
14. Franceschetti S, Binelli S, Casazza M, Lodrini S, Panzica F, Plachino F, Solero CL, Avanzini G (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumors. Acta Neurochir 103:47-51
15. Forsyth PA, Weaver S, Fulton D, Brasher PM, Sutherland G, Stewart D, Hagen NA, Barnes P, Cairncross JG, DeAngelis LM (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30:106-112
16. Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, Akerley W, Wahlberg L, Lekos A, Louis S (1996) A randomised, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46(4):985-991
17. Boarini DJ, Beck DW, VanGilder JC (1985) Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16:290-292
18. Levati A, Savoia G, Zoppi F, Boselli L, Tommasino C (1996) Peri-operative prophylaxis with phenitoin: Dosage and therapeutic plasma levels. Acta Neurochir 138:274-278
19. Temkin NR (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: Meta-analysis of controlled trials. Epilepsia 42:515-524
20. Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: A meta-analysis. Mayo Clin Proc 79:1489-1494
21. Schachter SC (1999) Oxcarbazepine: Current status and clinical applications. Exp Opin Invest Drugs 8(7):1103-1112
22. Schmidt D, Sachdeo R (2000) Oxcarbazepine for treatment of partial epilepsy: A review and recommendations for clinical use. Epilepsy Behav 1:396-405
23. Wellington K, Goa KL (2001) Oxcarbazepine: An update of its efficacy in management of epilepsy. CNS Drugs 15(2):137-163
24. Kleihues P, Cavanee WK (eds) (2000) World Health Organization classification of tumors. Pathology and genetics: Tumors of the Nervous system. IARC press, Lyon
25. Reynolds EH (1983) Early treatment and prognosis of epilepsy. Epilepsia 28:97-106
26. Vecht CJ, Wagner GL, Wilms EB (2003) Treating seizures in patients with brain tumors: Drug interactions between antiepileptic and chemotherapeutic agents. Sem Oncol 30(6 suppl 19):49-52
27. Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404-409
28. Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255-260
29. Beydoun A, Kutluay E (2001) Oxcarbazepine. Expert Opin Pharmacother 3(1):59-71
30. Tecoma ES (1999) Oxcarbazepine. Epilepsia 40(suppl 5):S37-S46
31. Grant SM, Faulds D (1992) Oxcarbazepine: A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 43:873-888
32. Lloyd P, Flesch G, Dieterle W (1994) Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 35(suppl 3):S10-S13
33. Perucca E (1999) The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia 40(suppl 9):S7-S13
34. 14C-oxcarbazepine in man. Xenobiotica 16:769-778
35. Jung H, Noguez A, Mayet L, Fuentes I, Gonzales-Esquivel DF (1997) The distribution of 10-hydroxycarbazepine in blood compartments. Biopharm Drug Disposit 18:17-23
36. Gonzalez-Esquivel DF, Ortega-Gavilan M, Alcantara-Lopez G, Jung-Cook H (2000) Plasma level monitoring of oxcarbazepine in epileptic patients. Arch Med Res 31(2):202-205
37. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR (1990) A randomised, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 323:497-502
38. Baruzzi A, Albani F, Riva R (1994) Oxcarbazepine: Pharmacokinetic interactions and their clinical relevance. Epilepsia 35(suppl 3):S14-S19
39. Larkin JG, Mckee PJ, Forrest G, Beastall GH, Park BK, Lowrie JI, Lloyd P, Brodie MJ (1991) Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects. Br J Clin Pharmacol 31:65-71
40. Sachdeo RC, Wasserstein A, Mesenbrik PJ, D'Souza J (2002) Effect of oxcarbazepine on sodium concentration and water handling. Ann Neurol 51:613-620